Epigallocatechin gallate – multiple host cell signaling proteins (EGCG targets)

Epigallocatechin gallate (EGCG) is the most abundant and bioactive catechin found in green tea (Camellia sinensis), recognized for its ability to interact with a diverse array of host cell signaling proteins rather than a single specific receptor. This multi-target profile allows EGCG to modulate numerous biological pathways, including those governing cell survival, apoptosis, and epigenetic regulation. A primary high-affinity target is the 67-kDa laminin receptor (67LR), which mediates many of EGCG's anti-cancer and anti-inflammatory activities by triggering specific intracellular signaling cascades. Beyond 67LR, EGCG is known to inhibit several key enzymes such as DNA methyltransferase 1 (DNMT1), matrix metalloproteinases (MMP-2 and MMP-9), and various receptor tyrosine kinases like EGFR and VEGFR (Singh et al., 2011, Life Sciences). These broad interactions contribute to its potential therapeutic roles in preventing and treating cancer, cardiovascular disorders, and neurodegenerative conditions. However, the clinical utility of EGCG is often limited by its poor systemic bioavailability and concerns regarding dose-dependent hepatotoxicity (EFSA Journal, 2018). Consequently, EGCG represents a complex pharmacological agent whose efficacy is derived from the simultaneous modulation of multiple cellular targets.

Other names

EGCG-binding proteinsGreen tea polyphenol targets67-kDa laminin receptor (67LR)DNA methyltransferase 1 (DNMT1)Matrix metalloproteinase-2 (MMP-2)Matrix metalloproteinase-9 (MMP-9)Epidermal growth factor receptor (EGFR)Vascular endothelial growth factor receptor (VEGFR)Insulin-like growth factor 1 receptor (IGF-1R)

Epigallocatechin gallate (EGCG) modulates multiple host cell signaling proteins through various mechanisms: it binds with high affinity to the 67-kDa laminin receptor (67LR) to induce apoptosis and inhibit cell migration (Tachibana et al., 2004, Nature Structural & Molecular Biology); it acts as a direct inhibitor of DNA methyltransferase 1 (DNMT1), promoting the reactivation of silenced tumor suppressor genes (Fang et al., 2003, Cancer Research); it inhibits the enzymatic activity of matrix metalloproteinases MMP-2 and MMP-9 to suppress tumor invasion and metastasis (Garbisa et al., 2001, Cancer); and it interferes with the phosphorylation of receptor tyrosine kinases such as EGFR and IGF-1R, thereby inhibiting downstream PI3K/Akt and MAPK signaling pathways (Khan et al., 2006, Life Sciences).